Commercial The Rare Journey Needs a Special Pharmacy Partner Drug ChannelsToday's guest post is from Bansi Nagji, Chief Executive Officer at PANTHERx Rare.CommercialRare DiseaseRead full story pharminent March 27, 2026 (Last updated: March 30, 2026) Drug Channels Today’s guest post is from Bansi Nagji, Chief Executive Officer at PANTHERx Rare. CommercialRare DiseaseRead full story Post navigation Previous: Merck’s deal for Terns sparks debate over a possible biotech bidding warNext: Novartis targets Xolair successor in buyout of startup Excellergy Related Stories Commercial Novo drops ‘Nordisk’ moniker, turns bull toward future in corporate rebrand pharminent September 14, 2026 Commercial Lilly’s $23B Q2 soars over expectations but Foundayo lags Novo’s rival oral GLP-1 pharminent August 5, 2026 Commercial Leqembi sales grow again after subcutaneous approvals pharminent July 29, 2026